Protherics PLC Notification of Director's Interests London, UK; Brentwood, TN, US: 13 June 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces the vesting, on 12 June 2008, of a Performance Share Award ("Award") to Saul Komisar, Director of Protherics PLC and President of Protherics Inc. under the terms of the Company's Deferred Bonus Plan. The Award was made on 12 June 2006 and vests two years from its Date of Grant. Pursuant to the vesting of the Award, the Company has today issued 27,594 Ordinary Shares to Saul Komisar at a nominal value of 2p per share. Following the above transaction, Saul Komisar holds 27,594 Ordinary Shares (0.008% of the total issued ordinary share capital of the Company of 340,366,655 Ordinary Shares.The above disclosure is made in accordance with Rule 3.1.4R of the Disclosure and Transparency Rules. / Ends / For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com